R Lindsay

Summary

Affiliation: Helen Hayes Hospital
Country: USA

Publications

  1. doi request reprint Effectiveness of risedronate and alendronate on nonvertebral fractures: an observational study through 2 years of therapy
    R Lindsay
    Helen Hayes Hospital, 51 55 Route 9W, West Haverstraw, NY 10993, USA
    Osteoporos Int 24:2345-52. 2013
  2. pmc The influence of lifestyle, menstrual function and oral contraceptive use on bone mass and size in female military cadets
    Jamie A Ruffing
    Clinical Research and Regional Bone Centers, Helen Hayes Hospital, West Haverstraw, NY, USA
    Nutr Metab (Lond) 4:17. 2007
  3. pmc Modeling the benefits of pamidronate in children with osteogenesis imperfecta
    Robert Lindsay
    Department of Medicine, Columbia University, Helen Hayes Hospital, West Haverstraw, New York 10993, USA
    J Clin Invest 110:1239-41. 2002
  4. doi request reprint Preventing osteoporosis with a tissue selective estrogen complex (TSEC) containing bazedoxifene/conjugated estrogens (BZA/CE)
    R Lindsay
    Clinical Research Center, Helen Hayes Hospital, Route 9W, West Haverstraw, NY 10993, USA
    Osteoporos Int 22:447-51. 2011
  5. ncbi request reprint Hormones and bone health in postmenopausal women
    Robert Lindsay
    Helen Hayes Hospital, West Haverstraw, NY, USA
    Endocrine 24:223-30. 2004
  6. ncbi request reprint Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women
    Robert Lindsay
    Internal Medicine, Helen Hayes Hospital, Rte 9W, West Haverstraw, NY 10993, USA
    JAMA 287:2668-76. 2002
  7. ncbi request reprint Longitudinal progression of fracture prevalence through a population of postmenopausal women with osteoporosis
    Robert Lindsay
    Helen Hayes Hospital, Route 9 W, West Haverstraw, NY 10993, USA
    Osteoporos Int 16:306-12. 2005
  8. ncbi request reprint Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis
    Robert Lindsay
    Regional Bone Center, Helen Hayes Hospital, West Haverstraw, NY 10993, USA
    Arch Intern Med 164:2024-30. 2004
  9. doi request reprint Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women
    Robert Lindsay
    Department of Medicine, Helen Hayes Hospital, West Haverstraw, New York, New York, and Columbia University, New York, New York, USA
    Fertil Steril 92:1045-52. 2009
  10. ncbi request reprint Risk of new vertebral fracture in the year following a fracture
    R Lindsay
    Helen Hayes Hospital, Route 9W, West Haverstraw, NY 10993, USA
    JAMA 285:320-3. 2001

Detail Information

Publications58

  1. doi request reprint Effectiveness of risedronate and alendronate on nonvertebral fractures: an observational study through 2 years of therapy
    R Lindsay
    Helen Hayes Hospital, 51 55 Route 9W, West Haverstraw, NY 10993, USA
    Osteoporos Int 24:2345-52. 2013
    ..This observational study showed that after 2 years, both risedronate and alendronate lowered the risk of hip and nonvertebral fractures compared with patients filling in a single bisphosphonate prescription...
  2. pmc The influence of lifestyle, menstrual function and oral contraceptive use on bone mass and size in female military cadets
    Jamie A Ruffing
    Clinical Research and Regional Bone Centers, Helen Hayes Hospital, West Haverstraw, NY, USA
    Nutr Metab (Lond) 4:17. 2007
    ..To determine the influence of menstrual irregularity, oral contraceptive use and other factors on bone mineral density (BMD) and bone size at different skeletal sites in 135 college-aged fit women...
  3. pmc Modeling the benefits of pamidronate in children with osteogenesis imperfecta
    Robert Lindsay
    Department of Medicine, Columbia University, Helen Hayes Hospital, West Haverstraw, New York 10993, USA
    J Clin Invest 110:1239-41. 2002
  4. doi request reprint Preventing osteoporosis with a tissue selective estrogen complex (TSEC) containing bazedoxifene/conjugated estrogens (BZA/CE)
    R Lindsay
    Clinical Research Center, Helen Hayes Hospital, Route 9W, West Haverstraw, NY 10993, USA
    Osteoporos Int 22:447-51. 2011
    ....
  5. ncbi request reprint Hormones and bone health in postmenopausal women
    Robert Lindsay
    Helen Hayes Hospital, West Haverstraw, NY, USA
    Endocrine 24:223-30. 2004
    ..The other outcomes in WHI make it important to define appropriate clinical guidelines for use of hormone therapy for prevention of fractures in postmenopausal women...
  6. ncbi request reprint Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women
    Robert Lindsay
    Internal Medicine, Helen Hayes Hospital, Rte 9W, West Haverstraw, NY 10993, USA
    JAMA 287:2668-76. 2002
    ..This lower-dose therapy's protection against loss of bone mineral density (BMD) associated with menopause has not been thoroughly investigated...
  7. ncbi request reprint Longitudinal progression of fracture prevalence through a population of postmenopausal women with osteoporosis
    Robert Lindsay
    Helen Hayes Hospital, Route 9 W, West Haverstraw, NY 10993, USA
    Osteoporos Int 16:306-12. 2005
    ..To determine the longitudinal progression of fractures through a population of osteoporotic women with no existing vertebral fractures...
  8. ncbi request reprint Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis
    Robert Lindsay
    Regional Bone Center, Helen Hayes Hospital, West Haverstraw, NY 10993, USA
    Arch Intern Med 164:2024-30. 2004
    ..Teriparatide (recombinant human parathyroid hormone [1-34]) reduces fracture risk in postmenopausal women with osteoporosis. We assessed the safety and incidence of new vertebral fractures after withdrawal of teriparatide...
  9. doi request reprint Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women
    Robert Lindsay
    Department of Medicine, Helen Hayes Hospital, West Haverstraw, New York, New York, and Columbia University, New York, New York, USA
    Fertil Steril 92:1045-52. 2009
    ..To evaluate the efficacy of the tissue-selective estrogen complex, bazedoxifene/conjugated estrogens (BZA/CE), for postmenopausal osteoporosis prevention...
  10. ncbi request reprint Risk of new vertebral fracture in the year following a fracture
    R Lindsay
    Helen Hayes Hospital, Route 9W, West Haverstraw, NY 10993, USA
    JAMA 285:320-3. 2001
    ..Vertebral fractures significantly increase lifetime risk of future fractures, but risk of further vertebral fractures in the period immediately following a vertebral fracture has not been evaluated...
  11. ncbi request reprint A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide
    Robert Lindsay
    Clinical Research Center, New York State Department of Health, Helen Hayes Hospital, West Haverstraw, New York 10993, USA
    J Bone Miner Res 21:366-73. 2006
    ..We show that 1 month of hPTH(1-34) treatment extends the bone-forming surface, increases mineral apposition rate, and initiates modeling-based formation...
  12. ncbi request reprint Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women
    Robert Lindsay
    Helen Hayes Hospital, Route 9 W, West Haverstraw, NY 10993, USA
    Osteoporos Int 16:372-9. 2005
    ..In summary, continued bone loss among early postmenopausal women treated with lower doses of CE or CE/MPA is uncommon...
  13. ncbi request reprint Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium
    Robert Lindsay
    Clinical Research Center, Helen Hayes Hospital, West Haverstraw, NY 10993, USA
    J Bone Miner Res 22:495-502. 2007
    ..Enhanced bone formation was associated with an increase in osteoblast apoptosis...
  14. ncbi request reprint Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal
    F Cosman
    Clinical Research Center, Helen Hayes Hospital, New York State Department of Health, West Haverstraw 10993, USA
    J Bone Miner Res 16:925-31. 2001
    ..Furthermore, PTH in combination with hormone therapy is an effective means of increasing bone mass throughout the skeleton and specifically reducing vertebral fracture occurrence by 75-100%, compared with HRT alone...
  15. ncbi request reprint Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat
    H Zhou
    Helen Hayes Hospital, New York State Health Department, West Haverstraw 10993-1195, USA
    J Bone Miner Res 16:1300-7. 2001
    ..We conclude that continuous administration of PTH and estrogen increases cortical porosity but has substantial beneficial effects on vertebral cancellous bone volume and cortical width in OVX rats...
  16. ncbi request reprint Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers
    E S Kurland
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    J Clin Endocrinol Metab 85:3069-76. 2000
    ....
  17. ncbi request reprint Short-term continuous infusion of human parathyroid hormone 1-34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL/J6 mice
    A Iida-Klein
    Regional Bone, Helen Hayes Hospital, West Haverstraw, New York 10993, USA
    J Endocrinol 186:549-57. 2005
    ..Short-term infusion of hPTH1-34 appears to be a good model to study the mechanisms underlying the catabolic action of PTH in mice...
  18. ncbi request reprint Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study
    D W Dempster
    Regional Bone Center, Helen Hayes Hospital. New York State Department of Health, West Haverstraw 10993, USA
    J Bone Miner Res 16:1846-53. 2001
    ..The results provide a structural basis for the recent demonstration that PTH treatment reduces the incidence of osteoporosis-related fractures...
  19. ncbi request reprint On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism
    D W Dempster
    Regional Bone Center, New York State Department of Health, Helen Hayes Hospital, West Haverstraw 10993, USA
    J Clin Endocrinol Metab 84:1562-6. 1999
    ....
  20. ncbi request reprint Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice
    Akiko Iida-Klein
    Regional Bone Center, Helen Hayes Hospital, New York State Department of Health, West Haverstraw 10993 1195, USA
    J Bone Miner Res 17:808-16. 2002
    ..In conclusion, PTH exerts an anabolic action at the tissue and cellular levels in intact mice and the magnitude and temporal pattern of this anabolic action, as assessed by densitometry and histomorphometry, are skeletal site specific...
  21. ncbi request reprint Effect of prior and ongoing raloxifene therapy on response to PTH and maintenance of BMD after PTH therapy
    F Cosman
    Clinical Research Center, Helen Hayes Hospital, West Haverstraw, NY 10993, USA
    Osteoporos Int 19:529-35. 2008
    ..6%, hip BMD increased 1.2-3.6% and radius BMD declined 4.3%. During the follow-up year, on continued raloxifene, BMD declined slightly at all sites except the femoral neck...
  22. ncbi request reprint Bone loss after cardiac transplantation
    Robert Lindsay
    Regional Bone Center, Helen Hayes Hospital, West Haverstraw, NY, USA
    N Engl J Med 350:751-4. 2004
  23. ncbi request reprint Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature
    F Cosman
    Clinical Research Regional Bone Centers, Helen Hayes Hospital, West Haverstraw, NY 10993, USA
    Thromb Res 116:1-13. 2005
    ..The objectives of this investigation were to compare the effects of these three treatments on hemostasis in a head to head randomized placebo-controlled trial...
  24. ncbi request reprint Calcium potentiates the effect of estrogen and calcitonin on bone mass: review and analysis
    J W Nieves
    Clinical Research Center, Helen Hayes Hospital, West Haverstraw, NY 10993, USA
    Am J Clin Nutr 67:18-24. 1998
    ..2%/y with calcitonin alone. These results suggest that a high calcium intake potentiates the positive effect of estrogen on bone mass at all skeletal sites and perhaps that of calcitonin on bone mass of the spine...
  25. doi request reprint Skeletal effects of vitamin D supplementation in postmenopausal black women
    J W Nieves
    Clinical Research and Regional Bone Centres, Helen Hayes Hospital, Route 9W, West Haverstraw, NY 10993, USA
    Calcif Tissue Int 91:316-24. 2012
    ..Vitamin D supplementation does not appear to influence bone loss in black women. However, in the FF polymorphism of the VDR gene group, vitamin D supplementation may retard the higher rate of bone loss...
  26. ncbi request reprint Practical clinical application of biochemical markers of bone turnover: Consensus of an expert panel
    P D Miller
    Department of Medicine, University of Colorado Health Sciences Center and Colorado Center for Bone Research, Denver, CO 80227, USA
    J Clin Densitom 2:323-42. 1999
    ..We will describe, in practical terms, how bone markers can be appropriately incorporated into clinical practice today...
  27. ncbi request reprint Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis
    M Parisien
    Regional Bone Center, Helen Hayes Hospital, New York State Department of Health, West Haverstraw
    J Bone Miner Res 7:913-9. 1992
    ..The data further support the hypothesis that in PHPT cancellous bone architecture is maintained...
  28. doi request reprint Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis
    R Lindsay
    Helen Hayes Hospital, West Havershaw, NY, USA
    Osteoporos Int 20:943-8. 2009
    ..In postmenopausal women with osteoporosis, increased duration of teriparatide versus placebo treatment was associated with a progressive decrease in the rates of nonvertebral fragility fractures and back pain...
  29. ncbi request reprint One year outcomes and costs following a vertebral fracture
    R Lindsay
    Helen Hayes Hospital, West Haverstraw, NY, USA
    Osteoporos Int 16:78-85. 2005
    ..These results suggest that therapies with proven, rapid efficacy may offer important economic value to healthcare payers, providers and patients...
  30. ncbi request reprint Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity
    Akiko Iida-Klein
    Helen Hayes Hospital, Regional Bone Center, West Haverstraw, NY 10993, USA
    Bone 40:391-8. 2007
    ..A cyclic PTH regimen was as effective as a daily regimen in improving cancellous and cortical bone microarchitecture and cellular activity in the murine vertebra...
  31. ncbi request reprint Daily and cyclic parathyroid hormone in women receiving alendronate
    Felicia Cosman
    Clinical Research Center, Helen Hayes Hospital, West Haverstraw, NY 10993, USA
    N Engl J Med 353:566-75. 2005
    ....
  32. ncbi request reprint Effects of cyclic versus daily hPTH(1-34) regimens on bone strength in association with BMD, biochemical markers, and bone structure in mice
    Akiko Iida-Klein
    Regional Bone Center, Helen Hayes Hospital, West Haverstraw, New York 10993, USA
    J Bone Miner Res 21:274-82. 2006
    ..The study supports further exploration of cyclic PTH regimens for the treatment of osteoporosis...
  33. ncbi request reprint Precision, accuracy, and reproducibility of dual X-ray absorptiometry measurements in mice in vivo
    Akiko Iida-Klein
    Regional Bone Center, Helen Hayes Hospital, West Haverstraw, NY 10993, USA
    J Clin Densitom 6:25-33. 2003
    ..We conclude that in vivo DXA BMD measurements in mice are very reliable with high precision and acceptable accuracy, and therefore useful for longitudinal studies of the mouse skeleton...
  34. ncbi request reprint Normal human osteoclasts formed from peripheral blood monocytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts
    David W Dempster
    Regional Bone Center, Helen Hayes Hospital, New York State Department of Health, West Haverstraw, New York 10993, USA
    J Cell Biochem 95:139-48. 2005
    ..This suggests a dual regulatory mechanism, whereby PTH acts both directly on osteoclasts and also, indirectly, via osteoblasts...
  35. ncbi request reprint The effects of combination of alendronate and human parathyroid hormone(1-34) on bone strength are synergistic in the lumbar vertebra and additive in the femur of C57BL/6J mice
    Sara Johnston
    Helen Hayes Hospital, Regional Bone Center, 51 North Route 9W, West Haverstraw, New York 10993, USA
    Endocrinology 148:4466-74. 2007
    ....
  36. pmc Retreatment with teriparatide one year after the first teriparatide course in patients on continued long-term alendronate
    Felicia Cosman
    Clinical Research Center, Helen Hayes Hospital, West Haverstraw, New York 10993, USA
    J Bone Miner Res 24:1110-5. 2009
    ..Retreatment with teriparatide may be a viable option for some patients with severe osteoporosis who have received prior teriparatide therapy...
  37. ncbi request reprint Therapeutic potential of parathyroid hormone
    Felicia Cosman
    Regional Bone Center, Helen Hayes Hospital, Route 9W, West Haverstraw, New York, NY 10993, USA
    Curr Osteoporos Rep 2:5-11. 2004
    ....
  38. ncbi request reprint Anabolic action of parathyroid hormone on cortical and cancellous bone differs between axial and appendicular skeletal sites in mice
    H Zhou
    Regional Bone Center, Helen Hayes Hospital, New York State Department of Health, West Haverstraw, NY 10993 1195, USA
    Bone 32:513-20. 2003
    ..Our results also support an interaction between PTH anabolic action and mechanical loading...
  39. ncbi request reprint Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations
    Anna N A Tosteson
    Department of Medicine, Dartmouth Medical School, and The Dartmouth Institute of Health Policy and Clinical Practice ANAT, Lebanon, NH 03756, USA
    Am J Manag Care 14:605-15. 2008
    ..To evaluate the cost-effectiveness of osteoporosis treatments for women at high fracture risk and estimate the population-level impact of providing bisphosphonate therapy to all eligible high-risk US women...
  40. ncbi request reprint The anabolic effects of parathyroid hormone
    M R Rubin
    Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Osteoporos Int 13:267-77. 2002
  41. pmc Alternative strategies for prevention of postmenopausal osteoporosis
    R Lindsay
    Columbia University, New York, NY
    Public Health Rep 104:66-70. 1989
    ..This review will deal primarily with the decision to introduce estrogen treatment, and the efficacy of estrogens,as well as alternative forms of prevention...
  42. ncbi request reprint Vitamin D economy in blacks
    Felicia Cosman
    Regional Bone Center and Clinical Research Centers, Helen Hayes Hospital, West Haverstraw, New York, USA
    J Bone Miner Res 22:V34-8. 2007
    ..Benefits of vitamin D supplements in blacks may still play a role, however, in the prevention of other chronic diseases...
  43. ncbi request reprint The effects of hormone replacement on the biomechanical properties of the uterosacral and round ligaments in the monkey model
    Michael D Vardy
    Columbia College of Physicians and Surgeons, New York, NY, USA
    Am J Obstet Gynecol 192:1741-51. 2005
    ....
  44. ncbi request reprint Males have larger skeletal size and bone mass than females, despite comparable body size
    Jeri W Nieves
    Clinical Research and Regional Bone Centers, Helen Hayes Hospital, West Haverstraw, New York 10993, USA
    J Bone Miner Res 20:529-35. 2005
    ..Despite comparable body size, males have greater BMC and BMD at the hip and distal tibia and greater tibial cortical thickness. This may confer greater skeletal integrity in males...
  45. ncbi request reprint Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment
    Richard Prince
    Department of Endocrinology and Diabetes and University of Western Australia, Sir Charles Gairdner Hospital, Nedlands, Australia
    J Bone Miner Res 20:1507-13. 2005
    ..The hazard ratio for combined teriparatide group (20 and 40 microg) for the 50-month period after baseline was 0.57 (p = 0.002), suggesting a sustained effect in reducing the risk of nonvertebral fragility fracture...
  46. ncbi request reprint Upper gastrointestinal tract safety of risedronate: a pooled analysis of 9 clinical trials
    Hugh Taggart
    Department of Health Care for the Elderly, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom
    Mayo Clin Proc 77:262-70. 2002
    ..The results of this extensive evaluation indicate that daily treatment with 5 mg of risedronate sodium is not associated with an increased frequency of adverse GI tract effects, even among patients at high risk for these events...
  47. ncbi request reprint Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment
    Barbara M Misof
    Ludwig Boltzmann Institute of Osteology and Fourth Medical Department, Hanusch Hospital and UKH Meidling, A 1140 Vienna, Austria
    J Clin Endocrinol Metab 88:1150-6. 2003
    ..The findings confirm the observations that PTH stimulates skeletal remodeling, resulting in an increased percentage of newly formed bone matrix of lower mineral density...
  48. ncbi request reprint What have we learned from clinical studies? Fractures and the interactions of bone mass and remodeling
    Robert Lindsay
    Osteoporos Int 14:S8-11. 2003
    ..Here we attempt to assemble the knowledge that we currently have about the mechanisms involved in fracture events...
  49. ncbi request reprint Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosis
    Anthony B Hodsman
    Department of Medicine, Lawson Health Research Institute, University of Western Ontario, London, Ontario, Canada N6A 4V2
    J Clin Endocrinol Metab 88:5212-20. 2003
    ..Dose-related incidences of transient hypercalcemia occurred, but only one patient (100-microg group) was withdrawn because of repeated hypercalcemia. Thus, full-length PTH was efficacious and safe over 12 months...
  50. ncbi request reprint Calcium and fracture risk
    Jeri W Nieves
    Am J Clin Nutr 86:1579-80. 2007
  51. ncbi request reprint Body composition during treatment with conjugated estrogens with and without medroxyprogesterone acetate: analysis of the women's Health, Osteoporosis, Progestin, Estrogen (HOPE) trial
    Ian H Thorneycroft
    Department of Obstetrics and Gynecology, University of South Alabama, Mobile, AL, USA
    Am J Obstet Gynecol 197:137.e1-7. 2007
    ..The objective of the study was to determine the effects of several doses of conjugated estrogens (CE) and CE plus medroxyprogesterone acetate (MPA) on body composition (BC)...
  52. ncbi request reprint Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk
    Nelson B Watts
    University of Cincinnati Osteoporosis Center, Cincinnati, OH, USA
    J Clin Densitom 7:255-61. 2004
    ..Although patients showing an increase in BMD had a lower fracture risk than patients showing a decrease in BMD, greater increases in BMD did not necessarily predict greater decreases in fracture risk...
  53. ncbi request reprint A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density
    Kenneth Saag
    University of Alabama School of Medicine, 1530 3rd Avenue South, FOT 820D, Birmingham, AL 35294 3408, USA
    Bone 40:1238-43. 2007
    ..v. infusion of ZOL 5 mg reduced urine NTX levels more rapidly than weekly oral ALN 70 mg. The majority of study patients preferred an i.v. treatment regimen of ZOL 5 mg over weekly osteoporosis therapy with ALN 70 mg...
  54. ncbi request reprint Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial
    Susan L Greenspan
    University of Pittsburgh, Osteoporosis Prevention and Treatment Center, Pittsburgh, Pennsylvania 15213, USA
    Ann Intern Med 146:326-39. 2007
    ..Recombinant human parathyroid hormone (1-84) (PTH) increases bone mass and strength and improves bone quality by stimulating new bone formation...
  55. ncbi request reprint Relation of lower-extremity amputation to all-cause and cardiovascular disease mortality in American Indians: the Strong Heart Study
    Helaine E Resnick
    Department of Epidemiology and Statistics, MedStar Research Institute, 6495 New Hampshire Ave, Suite 201, Hyattsville, MD 20783
    Diabetes Care 27:1286-93. 2004
    ..To compare risk of all-cause and cardiovascular disease (CVD) mortality in people with a lower-extremity amputation (LEA) attributable to diabetes and people without an LEA...
  56. ncbi request reprint Short-term urogenital effects of raloxifene, tamoxifen, and estrogen
    Michael D Vardy
    Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, USA
    Am J Obstet Gynecol 189:81-8. 2003
    ..The purpose of this study was to assess the urogenital effects of raloxifene, tamoxifen, conjugated equine estrogen, and placebo in healthy postmenopausal women...
  57. ncbi request reprint Health professional's guide to rehabilitation of the patient with osteoporosis
    Francis J Bonner
    Medical Director, Rehabilitation Hospital of South Jersey, Vineland, NJ, USA
    Osteoporos Int 14:S1-22. 2003
  58. ncbi request reprint Use of matched historical controls to evaluate the anti-fracture efficacy of once-a-week risedronate
    Nelson B Watts
    University of Cincinnati, Cincinnati, Ohio 45219, USA
    Osteoporos Int 14:437-41. 2003
    ..The use of appropriate historical control data provides an approach to the assessment of fracture effects in osteoporosis trials for which placebo-controlled data are not available...

Research Grants7

  1. A MECHANISTIC STUDY OF SKELETAL ACTIONS OF 1-34hPTH
    Robert Lindsay; Fiscal Year: 2009
    ..abstract_text> ..
  2. 6th International Symposium on Osteoporosis
    Robert Lindsay; Fiscal Year: 2005
    ..abstract_text> ..
  3. A MECHANISTIC STUDY OF SKELETAL ACTIONS OF 1-34hPTH
    Robert Lindsay; Fiscal Year: 2005
    ..abstract_text> ..
  4. A MECHANISTIC STUDY OF SKELETAL ACTIONS OF 1-34hPTH
    Robert Lindsay; Fiscal Year: 2006
    ..abstract_text> ..
  5. A MECHANISTIC STUDY OF SKELETAL ACTIONS OF 1-34hPTH
    Robert Lindsay; Fiscal Year: 2007
    ..abstract_text> ..
  6. A MECHANISTIC STUDY OF SKELETAL ACTIONS OF 1-34hPTH
    Robert Lindsay; Fiscal Year: 2006
    ..abstract_text> ..
  7. Cyclic Versus Daily Teriparatide on Bone Mass, Microstructure and Strength
    Robert Lindsay; Fiscal Year: 2010
    ..We believe that the periods where no TPTD is given in the cyclic regimen will allow for ongoing recovery of the supply of osteoblasts and will ultimately results in greater gains in bone mass and strength. ..